STOCKS TELEGRAPH

Tag: NYSE: XTNT

  • 3 Potentially Profitable Stocks Today Amidst Mixed Market Sentiment

    3 Potentially Profitable Stocks Today Amidst Mixed Market Sentiment

    Westwater Resources Inc [NASDAQ: WWR]

    Westwater Resources, Inc. has applauded President Trump’s Executive Order that was signed on September 30, 2020, declaring that United States’ reliance of foreign countries for the supply of critical minerals is a threat to the national security. This has seen the stock rally pre-market since the directive favors the company’s projects in the long run, especially on graphite production.

    Following this directive, the President has ordered the relevant departments to accelerate the issuance of permits and finance to companies involved in the mining and supply of the same within the US. These agencies include the Office of Science and Technology, the Secretary of Defense, Secretary of Energy and that of the Interior among others.

    Graphite and vanadium are critical minerals used in the technology industry and are thus a cause of concern to the country were their supply to be curtailed of cut off by foreign suppliers hence the order.

    Xtant Medical Inc [NYSE: XTNT]

    Xtant continues to gain upside momentum days after taking a move to restructure debt. In a move to reduce its outstanding debt, the company stated that it had ended its previously announced debt restructuring transaction. The aim of this transaction was to help improve the company’s capital structure by reducing its total debt. This reduction will enable Xtant access to capital markets and regain the compliance standards of getting listed in the NYSE. The company will now be in a position to get investment to stir up its growth.

    As part of the transaction, Xtant issued about 57.8 million shares of its common stock which they expected to raise about $40.8 million. This amount will represent part of the aggregate outstanding principal amount. There will also be another $21.1 million of outstanding of PIK interest.

    Alteryx Inc [NYSE: AYX]

    Alteryx is gaining quite strongly pre-market after releasing strong Q3 forecast. The company has announced that in the third quarter, it expects revenue ranging from $126 million to $128 million, an improvement from the earlier figures of $111 million to $115 million that they had issued on August 6, 2020.

    Further, Alteryx has announced that Mark Anderson, who is currently a board member, is set to replace current CEO and co-founder Dean Stoecker with immediate effect. Stoecker will now be an executive chairman and the chairman of the company’s board. This further strengthens the company’s future prospects and could see it gain significantly in the short-term.

     

  • 3 Stocks Braving Market Selloff after Trump Tests Positive for COVID-19

    3 Stocks Braving Market Selloff after Trump Tests Positive for COVID-19

    Equity markets have fallen sharply today all over the world. In the U.S, key indices are all in the red pointing to a potentially weak close to the week. In pre-market trading, the NASDAQ is down by 2%, the S&P 500 by 1.55%, and the Dow Jones by 1.46%.

    This follows news that the U.S president had tested positive for COVID-19. The president announced via twitter that together with his wife, they had tested positive for the virus and that they had started quarantine. This has thrown the markets into a spin as it indicates just how serious and unrelenting the virus is. It is also noteworthy that the number of infections continues to rise globally, and some countries have returned to strict lockdown measures shortly after easing them up.

    The number of deaths continues to rise too and recently crossed the one million mark. This points to a prolonged period of a disrupted global economy that could remain unstable until a vaccine is found. The worst part is that the news of the president contracting the virus has come just weeks to an election after a highly emotive campaign. However, even as overall market momentum points to weakness, there are stocks that are braving the selloff and doing quite well. Some of the pre-market gainers that could outperform the market today are as below:

    Nano-X Imaging Ltd [NASDAQ: NNOX]

    Nano-X Imaging Ltd is quite strong pre-market and is up by over 25%. This follows news that the company would do a live demonstration of its new imaging system at the RSNA 2020, between November 29th and December 5th. The company’s demonstration will incorporate a tech section for the company’s first commercial digital X-Ray that would be followed by a demonstration of the system handling both 2D and 3D procedures. The CEO said that they were excited about the demonstration as it exposed the growing depth of the company’s technology.

    Xtant Medical Holdings [NYSE: XTNT]

    Xtant Medical Holdings Inc is another top performer this morning and is up by over 100% in performer this morning.  This follows the company’s announcement that it had completed its debt restructuring process. The company stated that the goal of the restructuring is to cut down on total debt and help the company access the capital markets for future growth.

    Lonestar Resources U.S Inc [NASDAQ: LONE]

    Lonestar Resources U.S Inc is another top gainer today and is up by over 100%. This comes despite a downgrade of the company by Moody’s to D-PD after it filed for bankruptcy.

  • Top Performing Biotech Stocks amidst Mixed Market Sentiment

    Top Performing Biotech Stocks amidst Mixed Market Sentiment

    The markets are in mixed territory this afternoon. The NASDAQ is down due to a sharp drop in big tech stocks that make up a huge percentage of the index. On the other hand, the Dow and the S&P 5O0 are showing signs of strength. Besides big-tech price action, markets are still digesting the executive orders that President Trump signed over the weekend.

    The package includes a $400 unemployment payout that is only expected to last for a month. President Trump also deferred payroll taxes to the year’s end, but analysts are unsure that people will be willing to spend unless there is a change in the tax laws.

    Nonetheless, the executive order gave a boost to the economy, even as markets look to congress for a more detailed package. Despite the mixed signals that the markets are sending, there are stocks that are in huge gains at the moment.  Some of the top gainers this afternoon are biotech stocks that are driven by positive product development news. Below are some of the biggest movers in the day:

    Omeros Corporation [NASDAQ: OMER]

    Omeros Corporation has gained exponentially this afternoon and though volatile, it is still up by over 48%. The huge gains come after the company announced that it got a 100% recovery and survival rate for its COVID-19 treatment for patients with Acute Respiratory Distress Syndrome. The company announced that all 6 patients that took part in the study and needed ventilators before the treatment, survived and were discharged fully recovered.

    The company further stated that the treatment, called Narsoplimab, had led to an improvement in outcomes on all the markers that it was assessed. The company also stated that it was holding talks with different agencies of the American government for accelerated manufacture of this treatment.  The company is specifically holding discussions with the Department of Health and Human Services, the Biomedical Advanced Research Development Authority, and the National Institutes of Health Accelerating COVID-19 Therapeutic Interventions and Vaccines.

    Seres Therapeutics Inc. [NASDAQ: MCRB]

    Seres Therapeutics Inc. is another top performer this afternoon and is up by over 300%. This follows the company’s announcement that its late-stage drug test for its colon infections treatment was a success.  The company was testing for its treatment called SER-109. This is an oral treatment for a C. difficile, a dangerous lung treatment.  CEO Eric Shaff said that the FDA would likely find the results clinically meaningful.

    Xtant Medical Holdings Inc. [NYSE: XTNT]

    This is another top performer this afternoon and is up by over 85%. This follows the company’s announcement that it was restructuring its debts. The company announced that it had entered into an agreement with its lenders on a plan that will see it have a better capital structure, and access growth opportunities in the future.